Drug controllers for giving more time to manufacturers to withdraw combination drugs.

Health Ministry finalises new bill to counter spurious drugs with stricter penalties.

UK pharma shifts manufacturing overseas Indian or China.

Indian drug makers eye US firm Par Pharma - reports.